Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC3227297039;97040;97041 chr2:178543159;178543158;178543157chr2:179407886;179407885;179407884
N2AB3063192116;92117;92118 chr2:178543159;178543158;178543157chr2:179407886;179407885;179407884
N2A2970489335;89336;89337 chr2:178543159;178543158;178543157chr2:179407886;179407885;179407884
N2B2320769844;69845;69846 chr2:178543159;178543158;178543157chr2:179407886;179407885;179407884
Novex-12333270219;70220;70221 chr2:178543159;178543158;178543157chr2:179407886;179407885;179407884
Novex-22339970420;70421;70422 chr2:178543159;178543158;178543157chr2:179407886;179407885;179407884
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: Q
  • RefSeq wild type transcript codon: CAA
  • RefSeq wild type template codon: GTT
  • Domain: Fn3-123
  • Domain position: 71
  • Structural Position: 103
  • Q(SASA): 0.5024
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
Q/H None None 0.949 N 0.601 0.293 0.223146558224 gnomAD-4.0.0 1.59185E-06 None None None None N None 0 2.28645E-05 None 0 0 None 0 0 0 0 0
Q/R None None 0.722 N 0.567 0.218 0.176091768786 gnomAD-4.0.0 1.20034E-06 None None None None N None 0 0 None 0 0 None 0 0 1.31252E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
Q/A 0.2345 likely_benign 0.2004 benign -0.735 Destabilizing 0.633 D 0.629 neutral None None None None N
Q/C 0.7163 likely_pathogenic 0.68 pathogenic -0.106 Destabilizing 0.996 D 0.779 deleterious None None None None N
Q/D 0.4456 ambiguous 0.3993 ambiguous -0.515 Destabilizing 0.633 D 0.555 neutral None None None None N
Q/E 0.0939 likely_benign 0.0855 benign -0.393 Destabilizing 0.003 N 0.133 neutral N 0.370350076 None None N
Q/F 0.8289 likely_pathogenic 0.8109 pathogenic -0.351 Destabilizing 0.987 D 0.766 deleterious None None None None N
Q/G 0.3633 ambiguous 0.3131 benign -1.113 Destabilizing 0.775 D 0.67 neutral None None None None N
Q/H 0.3287 likely_benign 0.2922 benign -0.852 Destabilizing 0.949 D 0.601 neutral N 0.472623006 None None N
Q/I 0.4178 ambiguous 0.3868 ambiguous 0.24 Stabilizing 0.961 D 0.773 deleterious None None None None N
Q/K 0.12 likely_benign 0.1111 benign -0.318 Destabilizing 0.349 N 0.591 neutral N 0.436228352 None None N
Q/L 0.1879 likely_benign 0.1649 benign 0.24 Stabilizing 0.722 D 0.669 neutral N 0.486638529 None None N
Q/M 0.4044 ambiguous 0.3775 ambiguous 0.626 Stabilizing 0.987 D 0.594 neutral None None None None N
Q/N 0.3286 likely_benign 0.3046 benign -0.93 Destabilizing 0.775 D 0.535 neutral None None None None N
Q/P 0.178 likely_benign 0.1458 benign -0.054 Destabilizing 0.949 D 0.678 prob.neutral N 0.482328788 None None N
Q/R 0.1475 likely_benign 0.135 benign -0.276 Destabilizing 0.722 D 0.567 neutral N 0.454680826 None None N
Q/S 0.2615 likely_benign 0.2368 benign -1.075 Destabilizing 0.633 D 0.534 neutral None None None None N
Q/T 0.1808 likely_benign 0.1591 benign -0.747 Destabilizing 0.775 D 0.64 neutral None None None None N
Q/V 0.2578 likely_benign 0.2319 benign -0.054 Destabilizing 0.923 D 0.683 prob.neutral None None None None N
Q/W 0.7218 likely_pathogenic 0.7004 pathogenic -0.194 Destabilizing 0.996 D 0.78 deleterious None None None None N
Q/Y 0.6081 likely_pathogenic 0.5866 pathogenic 0.028 Stabilizing 0.987 D 0.73 prob.delet. None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.